Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
When semaglutide enters the bloodstream, it binds to receptors in the pancreas and brain which results in elevated GLP 1 levels
Looking ahead, we are focused on execution of a Phase 1 clinical trial for RT-114, a RaniPill capsule containing ProGens GLP-1 / GLP-2 dual-agonist, PG-102, and we are evaluating options to move forward with one or more additional molecules in the obesity space. Data Highlights The preclinical study evaluated the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of an incretin triagonist (GLP-1, GIP, glucagon receptors) when delivered via an endoscope-guided transenteric administration to mimic the RaniPill route of administration, versus the traditional administration route of subcutaneous (SC) injection
GIP adds metabolic improvements through pancreatic and fat tissue effects
Be sure to check local regulations at your destination for safe administration and disposal
